- SPIMACO

Saudi Stock Exchange (Kingdom of Saudi Arabia)

29.39 Last Update 14/12/2017 16:55 KSA

× lblWarning! {{companyMessage}}
  • :29.7
  • :29.3
  • ('000):120,000
  • (SAR '000):3,526,800
  • :0.92


  • 192,027
  • :133,625
  • :1.44
  • 52-W L52-W H
    29.39
    27.3541.4
  • 29.01%
  • 7.46%


  • 321

  • (SAR):

    5,666,310.85
  • (SAR):3,893,364
  • :1.46
  • Performance Comparison

Activities

Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO, also known as: Spimaco Addwaeih) is a public company, listed on the Saudi Stock Exchange since October 1993. It is involved in the manufacture and distribution of generic and licensed pharmaceuticals, and medical supplies. SPIMACO also holds the ownership of various joint stock companies and limited liability companies (LLCs) located within and outside Saudi Arabia. Through its main subsidiaries, SPIMACO also handles the manufacturing of petrochemicals, distribution of pharmaceutical products, and the manufacturing of medical supplies, including: gowns, draping packs and sterilization wraps. This Pharma giant was set up with a paid-up capital amounting to SR 1.2 billion in 1986. SPIMACO's main objective was to set up an advanced pharmaceutical industry in the kingdom, for the local production of medicines and medical appliances and to market these products inside Saudi Arabia and internationally too. Headquartered in Riyadh, SPIMACO has its main manufacturing unit located in Al-Qassim, where the quality standards adopted by the company have helped it win several awards of professional excellence, and quality certifications. As for its international collaborations, SPIMACO conducts pharmaceutical manufacturing under license & contract with Bristol-Myers Squibb, Lilly, Sanofi, Novartis, GSK, Bayer Healthcare and Roche. SPIMACO has licensing-in contracts with Meda, ViforPharma, Kyorin, Pharmathen, Esteve, EirgenPharma, Kern Pharma and Blue pharma. SPIMACO also holds licensing-out contracts with Janssen-Cilag, DMSCO and Hodaithy International Group.

  • Chairman:
    Saleh M. Al Khilaiwi
  • Board Members:

    Dr. Nazeeh H. Naseef

    Ibrahim R. Al Dughaither

    Abdurrahman M. Al Thunayyan

    Dr. Eisa J. M. Al Khalifa

    Dr. Waleed M. Al Shaqhaa

    Misfer A. Al Hamdan

    Tareq M. Al Fowzan

  • Auditors:

    Associated Accountants

Saudi Pharma. Indus. announces that The Addition of The Bonus Share (Tadawul - 21/04/2014)

Saudi Pharmaceutical Indust.& Med. Appliances Corp.’s EGM held on Thursday 17/04/2014 has approved ...

Read More ...

Saudi Pharmaceutical Company Holds Convention (Press Release - 18/03/2014)

The second version of Tabuk Cardiovascular Convention (2ndTCC) created a think tank for discussing ...

Read More ...

Saudi pharmaceutical co. to hold cardiovascular convention in Colombo (Arab News - 13/03/2014)

A leading Saudi-based pharmaceutical company is set to hold its second cardiovascular convention in ...

Read More ...

Read More ...
Announced On Period As Of Net Profit (SAR Mil) Growth (%)
08/11/2017 9-Month 30/09/2017 162 19.34
06/08/2017 6-Month 30/06/2017 153 19.92
04/05/2017 3-Month 31/03/2017 100 12.9
18/01/2017 12-Month 31/12/2016 377 5.5
18/10/2016 9-Month 30/09/2016 165 -54.97
Market Cap
US$ Mil
Last Price
Local Cry
Price Change (%)
1 Day
Price Change (%)
1 Year
P/E TTM P/B MRQ Dividend Yield (%) Beta ROA (%) ROE (%)
MOUASAT 2,050.51 154.49 -0.97 5.41 24.64 5.54 1.62 0.66 13.85 22.49
DALLAHHEALTH 1,571.17 99.98 -1.99 10.25 20.72 3.63 2 0.92 12.1 17.53
SPIMACO 939.51 29.39 0.23 -19.82 8.84 1.34 3.4 0.92 8.47 15.11
JULPHAR 631.74 2.29 -1.3 6.91 16.3 1.12 5.27 0.23 4.09 0
ATC.KSE 545.66 1,100 0 19.57 22.39 3.34 1.36 -0.03 2.93 12.88
CARE 499.84 41.94 0.31 -35.59 -217.74 1.95 1.79 0.95 -0.59 -0.89
MCGS 474.45 62 0 -5.78 26.48 1.82 2.94 0.99 5.74 6.87
GMPC 414.89 2.5 14.67 -12.8 1.04 1.16 3 -0.05 75.81 111.42
YIACO 105.28 175 0 -59.77 173.01 1.11 0 0.95 0.21 0.64
QGMD 19.16 6.03 -1.15 -40.14 -6.16 1.02 0 0.94 -6.18 0
NPMI 14.65 0.11 0 2.73 4.06 0.71 11.67 0.01 6.11 0
KCLINIC 0 0 0 0 0 0 0 0 0 -1.25